Psychedelic Clinical Trials
Find clinical trials studying psilocybin, MDMA, ketamine and other psychedelics. Many trials are actively recruiting participants who haven't found relief from conventional treatments.
A Phase 2 Open-Label Treatment Development Study of MDMA-Assisted Cognitive Processing Therapy (CPT) for Posttraumatic Stress Disorder (PTSD)
Remedy
Comparison of Nebulized Ketamine to Intravenous Sub-Dissociative Dose Ketamine for Pain
Antonios Likourezos
Low Dose Ketamine for Blunt Thoracic Trauma
North Memorial Health Care
Glutamate and Opioid Mechanisms of Antidepressant Response to Ketamine
King's College London
Single Ascending Dose Study With 5-MeO-DMT in Healthy Subjects
Beckley Psytech Limited
Study of SAGE-904 Using a Ketamine Challenge to Evaluate Electrophysiology, Safety, Tolerability, and Pharmacokinetics in Healthy Participants
Supernus Pharmaceuticals, Inc.
Entheogen Resurgence
Vireo Health
Repeated Neurocognitive Measurements in Depressed Patients
Rebecca Price
Ketamine As an Adjunctive Therapy for Major Depression (2)
University of Dublin, Trinity College
Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
University Hospital, Basel, Switzerland
Pharmacokinetic Study of Intranasal CT001 in Children 1-17 Years of Age Undergoing Elective Surgical Procedures
Cessatech A/S
Psilocybin Therapy for Depression and Anxiety in Parkinson's Disease
Joshua Woolley, MD, PhD
Role of the Serotonin 5-HT2A Receptor in Mescaline-induced Altered States of Consciousness
University Hospital, Basel, Switzerland
Repeat Dosing of Psilocybin in Migraine Headache
Yale University
Opioid Free Anesthesia and Bariatric Surgery
Northwell Health
Drug Effects on Interpersonal Interaction
University of Chicago
MDMA-Assisted Psychotherapy in Veterans With Combat-Related, Refractory PTSD
VA Loma Linda Health Care System
A Proof-of-Concept Trial on the Effect of Ketamine on Fatigue
National Institute of Nursing Research (NINR)
Open Label Randomized Multicenter to Assess Efficacy & Tolerability of Ofatumumab 20mg vs. First Line DMT in RMS
Novartis Pharmaceuticals
A Study of MELT-300 (Midazolam and Ketamine Sublingual Tablets) for Sedation and Intraoperative Ocular Analgesia in Participants Undergoing Cataract Extraction With Lens Replacement (CELR)
Melt Pharmaceuticals
Pharmacokinetics of GH001 in Healthy Volunteers
GH Research Ireland Limited
Effects of Dimethyltryptamine in Healthy Subjects
University Hospital, Basel, Switzerland
The Effect of Opioid-Free Anesthesia in TMJ Surgery
Massachusetts General Hospital
Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression
Central Institute of Mental Health, Mannheim
Adding Trauma-focused Psychotherapy to Ketamine Treatment for Chronic PTSD
Icahn School of Medicine at Mount Sinai
Precision Functional Brain Mapping in Psilocybin
Washington University School of Medicine
Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study
Imperial College London
Pilot RECAP Study in Healthy Volunteers
University of Wisconsin, Madison
Discontinuation of Disease Modifying Therapies (DMTs) in Multiple Sclerosis (MS): Extension of the DISCOMS Study
University of Colorado, Denver
Evaluation of Psilocybin in Anorexia Nervosa: Safety and Efficacy
University of California, San Diego
Ketamine Versus Fentanyl for Surgical Abortions
University of Washington
A Long-Term Extension Study for Participants With Treatment-resistant Major Depressive Disorder Who Are Continuing Esketamine Nasal Spray Treatment
Janssen-Cilag Ltd.
Effect of Postoperative Single Dose of Ketamine on Pain After Mastectomy
NYU Langone Health
An Efficacy and Safety of Proprietary Formulations of Oral Ketamine + Aspirin in Treatment of Acute Headache
Antonios Likourezos
A Comparison of Proprietary Formulations of Oral Ketamine + Aspirin and Oral Ketamine Alone for Musculoskeletal Pain
Antonios Likourezos
Modified Ketogenic Diet and Ketamine for Anorexia Nervosa
Homeostasis Therapeutics, LLC
The Impact of Perioperative Ketamine Infusion on Surgical Recovery
Vanderbilt University Medical Center
A Study of Oral Ibogaine in Opioid Withdrawal
atai Therapeutics, Inc.
Study of CT001 in Healthy Volunteers
Cessatech A/S
Ketamine-enhanced Prolonged Exposure Therapy in PTSD
VA Office of Research and Development
A Multi-Site Open-Label Extension Study of MDMA-Assisted Psychotherapy for PTSD
Lykos Therapeutics
Cognitive Behavioral Therapy Following Esketamine for Major Depression and Suicidal Ideation for Relapse Prevention
Yale University
Long-Term Safety and Effectiveness of MDMA-Assisted Therapy for PTSD
Lykos Therapeutics
RelieVRx for Total Knee Arthroplasty (TKA) for the Reduction of Acute Postoperative Pain and Opioid Use
AppliedVR Inc.
Safety and Efficacy of Psilocybin for Body Dysmorphic Disorder
New York State Psychiatric Institute
Effects of Dimethyl Fumarate on Cognitive Performance and Brain Abnormalities in Multiple Sclerosis.
IRCCS Centro Neurolesi Bonino Pulejo
Circulating Oxytocin Changes in Response to the Oxytocin System Stimulator MDMA in Patients With Diabetes Insipidus and Healthy Controls
University Hospital, Basel, Switzerland
SPL026 (DMT Fumarate) in Healthy Subjects and MDD Patients
Small Pharma Ltd
Browse by Condition
View all conditions →How to Join a Clinical Trial
Clinical trials are research studies that test new treatments. Participating can give you access to cutting-edge therapies while contributing to medical science. Each trial has specific eligibility criteria based on the research goals.
1. Review
Read the trial details, eligibility criteria, and what participation involves.
2. Contact
Reach out to the study team using the contact information provided.
3. Screen
Complete the screening process to determine if you're eligible.